Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tewari

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
Seminars in Oncology|April 1, 2009
Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology GroupKrishnansu S Tewari, Bradley J Monk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Evidence-based therapy for recurrent cervical cancerBradley J Monk, Krishnansu S Tewari
Journal of Gynecologic Oncology|August 1, 2017
Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical OncologyJuliet E Wolford, Krishnansu S Tewari
Expert Review of Clinical Pharmacology|October 11, 2014
Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignanciesRamez N Eskander, Krishnansu S Tewari
Therapeutic Advances in Medical Oncology|November 4, 2014
Targeting angiogenesis in advanced cervical cancerRamez N Eskander, Krishnansu S Tewari
Expert Opinion on Drug Metabolism & Toxicology|April 6, 2018
Pharmacokinetic drug evaluation of niraparib for the treatment of ovarian cancerTeresa C Longoria, Krishnansu S Tewari
Drugs|October 18, 2015
Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerationsTeresa C Longoria, Krishnansu S Tewari
Current Treatment Options in Oncology|March 3, 2016
New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP InhibitorsFong W Liu, Krishnansu S Tewari
Expert Opinion on Drug Metabolism & Toxicology|August 4, 2016
Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanomaTeresa C Longoria, Krishnansu S Tewari
Lancet (London, England)|March 23, 2024
Immunotherapy plus chemoradiotherapy in cervical cancer managementKrishnansu S Tewari, Bradley J Monk
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
Seminars in Oncology|April 1, 2009
Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology GroupKrishnansu S Tewari, Bradley J Monk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Evidence-based therapy for recurrent cervical cancerBradley J Monk, Krishnansu S Tewari
Journal of Gynecologic Oncology|August 1, 2017
Highlights from the Gynecologic Oncology Track at the 2017 Annual Meeting of the American Society of Clinical OncologyJuliet E Wolford, Krishnansu S Tewari
Expert Review of Clinical Pharmacology|October 11, 2014
Exploiting the therapeutic potential of the PI3K-AKT-mTOR pathway in enriched populations of gynecologic malignanciesRamez N Eskander, Krishnansu S Tewari
Therapeutic Advances in Medical Oncology|November 4, 2014
Targeting angiogenesis in advanced cervical cancerRamez N Eskander, Krishnansu S Tewari
Expert Opinion on Drug Metabolism & Toxicology|April 6, 2018
Pharmacokinetic drug evaluation of niraparib for the treatment of ovarian cancerTeresa C Longoria, Krishnansu S Tewari
Drugs|October 18, 2015
Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerationsTeresa C Longoria, Krishnansu S Tewari
Current Treatment Options in Oncology|March 3, 2016
New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP InhibitorsFong W Liu, Krishnansu S Tewari
Expert Opinion on Drug Metabolism & Toxicology|August 4, 2016
Evaluation of the pharmacokinetics and metabolism of pembrolizumab in the treatment of melanomaTeresa C Longoria, Krishnansu S Tewari
Lancet (London, England)|March 23, 2024
Immunotherapy plus chemoradiotherapy in cervical cancer managementKrishnansu S Tewari, Bradley J Monk
Pageof 35